Cutting Edge Developments: Treatment in development, technology-based clinical measures, and predicting progression in MS
Presenters at the cutting-edge developments in MS session at #ACTRIMS deliver the latest key findings on pivotal studies. At the session, we heard…
Emerging Concepts in MS: MRI measure as an indicator of potential conversion to SPMS, novel therapeutic targets of neuroinflammation, and roles of biological measures of aging in MS
Presenters at the emerging concepts in MS session at the ACTRIMS 2019 Forum deliver results on novel research areas in MS. At the…
Leading researchers to present on MS discoveries at the fourth annual ACTRIMS Forum 2019
The research team will be attending the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2019. We are excited to…
ECTRIMS 2018: Catching up with the MS-Society funded collaborative team that is working to improve cognition in people with progressive MS
The Multiple Sclerosis Society of Canada announced last month a $5 million grant in support of the first, international, multicenter clinical trial to investigate cognitive…
Guten Tag! The research team will be live at the world’s largest conference in Berlin, Germany next week
The MS Society of Canada’s research team is preparing to fly over the Atlantic to the exciting city of Berlin, Germany to attend…
3rd Scientific Congress of the Progressive MS Alliance: Making a difference through rehabilitation and Symptom Management (Part 3)
While researchers are forging ahead with great ideas in symptom management and rehabilitation, we also heard about the complexity of factors that affect…
3rd Scientific Congress of the Progressive MS Alliance: Making a difference through rehabilitation and Symptom Management (Part 2)
Taking the lessons learned from stroke research (part 1) and moving forward to develop new projects and programs is important for the advancement…
